Form 13F-HR MIZUHO SECURITIES USA For: Mar 31
http://archive.fast-edgar.com/20240510/AJ22RG2CZ2259ZZZ2Q2B2ZO22SUGVZ22Z262
Filed on: May 10, 2024
Form 8-K UNITED BANKSHARES INC/WV For: May 09
UNITED BANKSHARES INC/WV false 0000729986 0000729986 2024-05-09 2024-05-09
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported):
May 9, 2024
(Exact name of registrant as specified in its charter)
West Virginia No. 002-86947 ... (continue reading...)
Form 10-Q Soho House & Co Inc. For: Mar 31
false£--12-310001846510€Q1€€March 31, 2027March 31, 2027September 30, 2024 September 30, 2024 January 31, 2028January 31, 2028January 31, 2028January 31, 2025July 31,... (continue reading...)
Form D Trially Mar 2024 a Serie
.FormData {
color: blue;
background-color: white;
font-size: 12px;
font-family: Times, serif;
}
.FormDataR {
color: blue;
background-color: white;
font-size: 12px;
font-family: Times, serif;
text-align: right;
}
.SmallFormData {
color: blue;
background-color: white;
font-size: 10px;
font-family: Times, serif;
}
.FootnoteData {
color:... (continue reading...)
Form 8-K Sphere Entertainment For: May 10
FALSE000179525000017952502024-05-102024-05-10UNITED STATESSECURITIES AND EXCHANGE COMMISSIONWASHINGTON, DC 20549FORM 8-KCURRENT REPORTPursuant to Section 13 or 15(d)of The Securities Exchange Act of 1934Date of report (Date of earliest event reported): May 10, 2024SPHERE ENTERTAINMENT CO.(Exact Name of Registrant as Specified in Charter)Delaware001-3924584-3755666(State or other jurisdictionof incorporation)(CommissionFile Number)(IRS EmployerIdentification No.)Two... (continue reading...)
More SEC Filings
View Older Stories-
Form 8-K Soho House & Co Inc. For: May 10
-
Form 8-K Neurogene Inc. For: May 10
-
Form SD Vontier Corp
-
Form 10-Q Akero Therapeutics, Inc. For: Mar 31
-
Form 10-Q Inspired Entertainment, For: Mar 31
-
Form 10-Q Wave Life Sciences Ltd. For: Mar 31
-
Form 4 PLUS THERAPEUTICS, INC. For: May 08 Filed by: HEDRICK MARC H
-
Form 4 PLUS THERAPEUTICS, INC. For: May 08 Filed by: Sims Andrew John Hugh MacIntyre
-
Form 8-K OVERSEAS SHIPHOLDING For: May 10
-
Form 4 PLUS THERAPEUTICS, INC. For: May 08 Filed by: Clowes Howard
-
Form DEFR14A SHF Holdings, Inc.
-
Form 4 PLUS THERAPEUTICS, INC. For: May 08 Filed by: Petersen Greg
-
Form 4 PLUS THERAPEUTICS, INC. For: May 08 Filed by: Hawkins Richard J
-
Form 4 PLUS THERAPEUTICS, INC. For: May 08 Filed by: Lenk Robert P
-
Form 4 Westlake Chemical Partne For: May 08 Filed by: Kenner Andrew
-
Form 10-Q American Strategic Inves For: Mar 31
-
Form 10-Q Deciphera Pharmaceutical For: Mar 31
-
Form 8-K United Homes Group, Inc. For: May 10
-
Form 8-K American Strategic Inves For: May 10
-
Form D/A Parsifal Offshore Ltd.
-
Form 13F-HR HOMESTEAD ADVISERS CORP For: Mar 31
-
Form 8-K Star Holdings For: May 10
-
Form 10-Q Protalix BioTherapeutics For: Mar 31
-
Form D/A Parsifal Fund, LP
-
Form 8-K Douglas Elliman Inc. For: May 09
-
Form 8-K Akero Therapeutics, Inc. For: May 10
-
Form 8-K SANUWAVE Health, Inc. For: May 10
-
Form SD BECTON DICKINSON & CO
-
Form D/A Parsifal Master Fund
-
Form 8-K Sylvamo Corp For: May 10
-
Form 8-K Inspired Entertainment, For: May 10
-
Form 8-K Workhorse Group Inc. For: May 10
-
Form 10-Q Star Holdings For: Mar 31
-
Form 13F-HR Banco Santander, S.A. For: Mar 31
-
Form 6-K Crescent Point Energy For: May 10
-
Form 10-Q Luminar Technologies, For: Mar 31
-
Form 10-Q Instil Bio, Inc. For: Mar 31
-
Form 8-K Aeluma, Inc. For: May 10
-
Form 10-Q ANI PHARMACEUTICALS INC For: Mar 31
-
Form 8-K Mondee Holdings, Inc. For: May 10
-
Form D CR-0318 Fund II, a serie
-
Form 13F-NT Grupo Empresarial Santan For: Mar 31
-
Form D/A Dark Forest Global Equit
-
Form 13F-HR Intermede Investment For: Mar 31
-
Form 8-K Humacyte, Inc. For: May 10
-
Form 8-K i3 Verticals, Inc. For: May 10
-
Form 8-K PROKIDNEY CORP. For: May 10
-
Form 8-K TruBridge, Inc. For: May 10
-
Form 424B3 Goodness Growth Holdings
-
Form 10-Q ENBRIDGE INC For: Mar 31